文献速递瓣膜外科

微创二尖瓣手术中经胸钳夹与主动脉内球囊阻断的系统评价与荟萃分析

Transthoracic clamp versus endoaortic balloon occlusion in minimally invasive mitral valve surgery: a systematic review and meta-analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该系统评价与荟萃分析纳入11项观察性研究共4181例微创二尖瓣手术患者,比较经胸钳夹(TTC)与主动脉内球囊阻断(EABO)的结局。TTC组主动脉夹层风险显著低于EABO组(RR 0.33,95%CI 0.12-0.93,P=0.04),术后死亡或脑血管意外风险无差异。主动脉阻断时间总体无差异,但亚组分析显示TTC较股动脉插管EABO阻断时间更短,而主动脉插管EABO较TTC更短。

要点

  • TTC组主动脉夹层风险显著低于EABO组(RR 0.33,95%CI 0.12-0.93,P=0.04)。
  • 两种技术术后死亡或脑血管意外风险无差异。
  • 主动脉阻断时间因EABO插管路径不同而异,需个体化选择。

核心结论

  • 尽管EABO主动脉夹层风险较高,但两种技术术后生存率和脑血管意外发生率相似。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline和Embase至2018年12月,最终纳入11项观察性研究共4181例参与者。

主要发现

  • 术后死亡或脑血管意外风险在TTC与EABO间无差异证据。
  • 主动脉夹层:TTC组4/1590 vs EABO组19/2492,RR 0.33(95%CI 0.12-0.93;P=0.04)。
  • 主动脉阻断时间总体无差异(MD -5.17 min,95%CI -12.40至2.06;P=0.16)。
  • TTC较股动脉插管EABO主动脉阻断时间更短(MD -9.26 min,95%CI -17.00至-1.52;P=0.02)。
  • 主动脉插管EABO较TTC主动脉阻断时间更短(MD 7.77 min,95%CI 3.29-12.26;P<0.001)。

关键数值与推荐

  • 主动脉夹层风险比0.33(95%CI 0.12-0.93;P=0.04),支持TTC。
  • 主动脉阻断时间总体均数差-5.17 min(95%CI -12.40至2.06;P=0.16),无差异。
  • TTC vs 股动脉插管EABO主动脉阻断时间均数差-9.26 min(95%CI -17.00至-1.52;P=0.02)。
  • 主动脉插管EABO vs TTC主动脉阻断时间均数差7.77 min(95%CI 3.29-12.26;P<0.001)。
  • TTC vs 股动脉插管EABO体外循环时间均数差-10.08 min(95%CI -19.93至-0.22;P=0.05)。

临床怎么用

  • 选择主动脉阻断方式时需权衡主动脉夹层风险与阻断时间,TTC可能降低夹层风险。
  • EABO的插管路径影响阻断时间,股动脉插管时TTC阻断时间更短,主动脉插管时EABO更短。

局限性

  • 纳入研究均为观察性研究,可能存在选择偏倚和混杂。
  • 检索截止至2018年12月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This systematic review and meta-analysis aims to determine outcomes following aortic occlusion with the transthoracic clamp (TTC) versus endoaortic balloon occlusion (EABO) in patients undergoing minimally invasive mitral valve surgery. A subgroup analysis compares TTC to EABO with femoral cannulation separately from EABO with aortic cannulation. We searched Medline and Embase up to December 2018. Two people independently and in duplicate screened title and abstracts, full-text reports, extracted data and assessed the risk of bias using the Cochrane risk-of-bias tool for non-randomized studies. We identified 1564 reports from which 11 observational studies with 4181 participants met the inclusion criteria. We found no evidence of difference in the risk of postoperative death or cerebrovascular accident (CVA) between the 2 techniques. Evidence for a reduction in aortic dissection with TTC was found: 4 of 1590 for the TTC group vs 19 of 2492 for the EABO group [risk ratio 0.33, 95% confidence interval (CI) 0.12-0.93; P = 0.04]. There was no difference in aortic cross-clamp (AoX) time between TTC and EABO [mean difference (MD) -5.17 min, 95% CI -12.40 to 2.06; P = 0.16]. TTC was associated with a shorter AoX time compared to EABO with femoral cannulation (MD -9.26 min, 95% CI -17.00 to -1.52; P = 0.02). EABO with aortic cannulation was associated with a shorter AoX time compared to TTC (MD 7.77 min, 95% CI 3.29-12.26; P < 0.001). There was no difference in cardiopulmonary bypass (CPB) time between TTC and EABO with aortic cannulation (MD -4.98 min, 95% CI -14.41 to 4.45; P = 0.3). TTC was associated with a shorter CPB time compared to EABO with femoral cannulation (MD -10.08 min, 95% CI -19.93 to -0.22; P = 0.05). Despite a higher risk of aortic dissection with EABO, the rates of survival and cerebrovascular accident across the 2 techniques are similar in minimally invasive mitral valve surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Rival PM, Moore THM, McAleenan A, et al. Transthoracic clamp versus endoaortic balloon occlusion in minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2019. PMID: 30715347. doi:10.1093/ejcts/ezy489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。